Patent primer - Medical treatment inventions

被引:0
|
作者
Soames, C [1 ]
机构
[1] D Young & Co, London EC1 2DY, England
关键词
D O I
10.1038/nrd1908
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Although methods of medical treatment per se are not patentable in Europe, the use of agents or products in the preparation of medicaments for such treatments are. The drawbacks of such limited protection is clear. The European Patent Office is becoming ever more stringent in their requirements for the presence of experimental data in support of the medical use to be present in the application on filing. Whether Europe will ever harmonize with the US in allowing the protection of medical methods is not clear. Until then the burden on inventors to obtain patent protection for medical-use-type inventions is significant and the return is far from adequate.
引用
收藏
页码:951 / 951
页数:1
相关论文
共 50 条